N Jeandidier Selected Research

Autoimmune Diseases (Autoimmune Disease)

11/2006

Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Jeandidier Research Topics

Disease

4	Hyperglycemia 03/2013 - 12/2000
3	Hypoglycemia (Reactive Hypoglycemia) 02/2008 - 12/2000
2	Inflammation (Inflammations) 01/2016 - 06/2015
2	Type 2 Diabetes Mellitus (MODY) 09/2015 - 09/2006
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2012 - 01/2001
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 02/2010 - 11/2007
2	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2010 - 10/2002
2	Diabetes Mellitus 09/2008 - 09/2008
1	Hypoxia (Hypoxemia) 01/2016
1	Body Weight (Weight, Body) 01/2011
1	Infections 01/2011
1	Dyslipidemias (Dyslipidemia) 02/2010
1	Infertility (Sterility) 02/2010
1	Hyperandrogenism 02/2010
1	Glucose-Galactose Malabsorption 02/2010
1	Ketosis 09/2008
1	Diabetes Complications 09/2008
1	Insulinoma 02/2008
1	Neuroendocrine Carcinoma 02/2008
1	Renal Insufficiency (Renal Failure) 02/2008
1	Glucose Intolerance 11/2007
1	Familial Partial Lipodystrophy (Dunnigan Syndrome) 11/2007
1	Insulin Resistance 11/2007
1	Hypertriglyceridemia 11/2007
1	Autoimmune Diseases (Autoimmune Disease) 11/2006
1	Hashimoto Disease (Thyroiditis, Hashimoto) 11/2006
1	Hyperthyroidism 11/2006
1	Vitiligo 11/2006
1	Communicable Diseases (Infectious Diseases) 06/2006
1	Critical Illness (Critically Ill) 06/2006
1	Hyperplasia 02/2002
1	Carcinoma (Carcinomatosis) 02/2002
1	Exfoliative Dermatitis (Erythroderma) 02/2002
1	Mycosis Fungoides 02/2002

Drug/Important Bio-Agent (IBA)

10	Insulin (Novolin)FDA Link 03/2013 - 12/2000
4	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 02/2008
2	CytokinesIBA 01/2016 - 06/2006
2	Hypoglycemic Agents (Hypoglycemics)IBA 09/2015 - 02/2008
2	C-PeptideIBA 01/2011 - 02/2008
2	Metformin (Glucophage)FDA LinkGeneric 02/2010 - 11/2007
2	Blood Glucose (Blood Sugar)IBA 09/2006 - 12/2000
2	Insulin Lispro (Humalog)FDA Link 09/2006 - 12/2000
1	Exenatide (Byetta)FDA Link 09/2015
1	Thrombin FDA Link 06/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	ProinsulinIBA 02/2008
1	Diazoxide (Hyperstat)FDA Link 02/2008
1	lanreotide (Somatuline)FDA Link 02/2008
1	Chromogranin AIBA 02/2008
1	Pioglitazone (Actos)FDA Link 11/2007
1	Biological ProductsIBA 11/2007
1	Lamin Type A (Lamin A)IBA 11/2007
1	Intrinsic Factor FDA Link 11/2006
1	Insulin AntibodiesIBA 11/2006
1	AntibodiesIBA 11/2006
1	Anti-Idiotypic AntibodiesIBA 11/2006
1	NF-kappa B (NF-kB)IBA 06/2006
1	Complement System Proteins (Complement)IBA 06/2006
1	Pharmaceutical PreparationsIBA 02/2002
1	Calcitonin Gene-Related PeptideIBA 02/2002
1	Vasodilator Agents (Vasodilators)IBA 02/2002
1	SteroidsIBA 02/2002
1	Pentagastrin (Peptavlon)FDA Link 02/2002
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 02/2002
1	Short-Acting InsulinIBA 12/2000

Therapy/Procedure

4	Therapeutics 09/2015 - 02/2002
1	Injections 01/2016
1	Thyroidectomy 02/2002